Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam IV infusion or bolus adjunctive therapy safety trial in epilepsy
2008-004714-27Phase 3Completed
- Sponsor
- UCB
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of brivaracetam in epilepsy and generalized epilepsy (4 arms), sponsored by UCB. Primary endpoint: Safety variables. Started Jan 2009; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsygeneralized epilepsy
Beyond the preview
Go deeper on 2008-004714-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004714-27.